---
category: news
title: "Iktos and Facio Therapies Announce Collaboration to Use AI for FSHD Drug Design"
excerpt: "Iktos, a company specialized in Artificial Intelligence for new drug design, and Facio Therapies, a drug discovery and development company focused on developing treatments for facioscapulohumeral dystrophy (FSHD),"
publishedDateTime: 2021-05-11T06:00:00Z
originalUrl: "https://www.businesswire.com/news/home/20210510006014/en/Iktos-and-Facio-Therapies-Announce-Collaboration-to-Use-AI-for-FSHD-Drug-Design"
webUrl: "https://www.businesswire.com/news/home/20210510006014/en/Iktos-and-Facio-Therapies-Announce-Collaboration-to-Use-AI-for-FSHD-Drug-Design"
type: article
quality: 15
heat: 15
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "Ld7zrimlI3Hm5S3YWXxw/Sg09gbINr2pEstvmPcs3FFNcziP7VjzZgn4BJoVl/n0Xtlqf2LOBYcU/bJTy0KjPrTbUS7u5h4+azw6mUFTw0Bte+JR3Ne5SiQ56PM0xIAadUFTQEHE7Z97nMyeTpKS9PjK231xzS59yvA4f3qDX832JUHsdxAkzzA5NXn3SOIAr+lPRwZJLYPVvMQr6pxr+ZaPbIhVcKiPFqrSyum/M+NoN4fzTvG8EpYePLKFoHwvIAOV641PaBUU5Ez40whEhq8hzmBsT/245PzDMPsBjnzLNIJGmz5m1gyqiQULlIIOl2D7tQF1SRuWn+tQAjJlLfnREvTnW8wRUpeGnFxYviU=;XdarE0tCuT6M8wHxzNDq6w=="
---

